Qiagen NV has appointed Jonathan Pratt as its new chief executive officer, as talks with private equity firms about a possible sale of the European molecular testing company progress.
Qiagen NV has appointed Jonathan Pratt as its new chief executive officer, as talks with private equity firms about a possible sale of the European molecular testing company progress.
Lire l’article complet sur le site source
Bloomberg — Markets (EN)